Early Feasibility Clinical Study of the VitalFlow Stimulator, an Emergence Treatment for Ischemic Stroke
The National Institute of Health hereby awards a grant in the amount of $1,486,705 (see “Award Calculation” in section I and “Terms and Conditions” in Section III) to NERVIVE, INC. in support of the above referenced project. The award is pursuant to the authority of 42 USC 241 31 USC 6305 15 USC 638 42 CFR 52 and is subject to the requirements of this statute and regularion and of other referenced, incorporated or attached terms and conditions.
Nervive awarded $3.1 Million NIH grant to develop the VitalFlow™ stimulator, a noninvasive emergency treatment for ischemic stroke
Nervive, Inc. has been awareded a $3.1 million grant from the National Institutes of Health to advance clinical testing of its medical device, the VitalFlow™ stimulator, as an emergency treatment for stroke. The three-year grant has been awarded through the CREATE Devices program that provides a collaborative partnership with the National Institute of Neurological Disorders and Stroke (NINDS).